Braskem (BAK) Earnings Analysis

Braskem (BAK) next reports earnings on 2026-08-12, consensus EPS 1.21 USD. Last quarter (2026-05-11) it beat with EPS 0.711 USD vs 0.2063 USD est (+244.6%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E n/a.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BAK next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate1.21 USD
Revenue estimate4.42B

BAK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-110.711 USD0.2063 USD+244.6%Beat
2026-03-27-0.48 USD-0.98 USD+51%Beat
2025-08-07-0.14 USD-0.7 USD+80%Beat
2025-05-120.3 USD0.03 USD+900%Beat
2025-02-27-0.39 USD-0.38 USD-2.6%Miss
2024-11-070.08 USD0.02 USD+300%Beat

Beat rate: 5/6 (83%) over reported quarters with consensus data.

BAK valuation and analyst view

Trailing P/En/a
Trailing EPSn/a
Price / bookn/a
Dividend yieldn/a
Market cap0.97B
Analyst consensusHold (2 buy / 3 hold / 1 sell)
Avg price target2.65 USD

Related research pages

Frequently asked questions

When is Braskem (BAK)'s next earnings date?

Braskem is next scheduled to report on 2026-08-12, with a consensus EPS estimate of 1.21 USD and revenue estimate of 4.42B.

Did BAK beat earnings last quarter?

In its 2026-05-11 report, BAK posted EPS of 0.711 USD versus a 0.2063 USD estimate — a beat of 244.6%.

What is BAK's earnings track record?

Over the last 6 reported quarters with consensus data, BAK beat estimates 5 times (83%).

What is BAK's current P/E ratio and EPS?

BAK trades at a trailing P/E of n/a on trailing EPS of n/a.

What do analysts rate BAK?

Analyst consensus is "Hold" across 6 ratings (0 strong buy, 2 buy, 3 hold, 1 sell, 0 strong sell). Average 12-month price target: 2.65 USD.